Detalhe da pesquisa
1.
Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study.
Eur J Haematol
; 112(5): 765-775, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38223989
2.
IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy.
Haemophilia
; 29(1): 135-144, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423202
3.
Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia.
Eur J Haematol
; 82(3): 235-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19067738
4.
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.
Cancer Med
; 8(6): 2802-2809, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30997748
5.
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.
Eur J Cancer
; 60: 154-65, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27127905
6.
Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab.
Oncol Lett
; 9(3): 1327-1332, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25663907
7.
Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.
Hematol J
; 4(5): 346-50, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14502260
8.
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey.
Leuk Lymphoma
; 55(4): 841-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23829282
9.
Transfusion-dependent low-risk myelodysplastic patients receiving deferasirox: Long-term follow-up.
Oncol Lett
; 6(6): 1774-1778, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24260074
10.
Complete remission induced by high dose erythropoietin and granulocyte colony stimulating factor in acute erythroleukemia (AML-M6 with maturation).
Haematologica
; 87(11): 1225-7, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12414355